Results 51 to 60 of about 242 (180)

Клинические и морфологические особенности повреждения миокарда и течения фульминантного миокардита на фоне СOVID-19, диагностика и тактика лечения [PDF]

open access: yes, 2020
In a review article based on my own clinical experience of managing patients with acute myocardial injury and fulminant myocarditis, taking into account expert recommendations on the clinical treatment of myocardial damage associated with novel ...
Zayratyants O.V.   +19 more
core   +5 more sources

The mRNA expression character of iNOS and eNOS in the rats myocardium with alcoholic cardiomyopathy during metabolitotropic cardioprotectors therapy

open access: yes, 2017
В останній час у якості ще одного механізму ушкодження міокарду при алкоголізмі стали розглядати систему NO. У наш час майже відсутні роботи про характер експресії мРНК iNOS та еNOS в міокарді при алкогольній кардіоміопатії та медикаментозної корекції ...
Бєленічев, Ігор Федорович   +7 more
core   +1 more source

Risk Factors Related with Doxorubicin-Induced Cardiotoxicity [PDF]

open access: yes, 2018
The aim of this thesis was to evaluate risk factors related with cardiotoxicity for patients who were treated with doxorubicin. Objectives: to evaluate risk factors (age, family history of cardiovascular disease, smoking) related with doxorubicin-induced
Ambrazevičiūtė, Gretė
core  

Strategy of non-drug management of metabolic syndrome, which is accompanied by prediabetes and hypertension

open access: yesMìžnarodnij Endokrinologìčnij Žurnal
Background. The condition of prediabetes implies the possibility to achieve stable normal glycemic indicators in order to prevent the further development of diabetes without using drug therapy.
G. Myhalchyshyn   +2 more
doaj   +1 more source

Дослідження кардіопротекторних властивостей густого екстракту «Кардіоcтен». [PDF]

open access: yes, 2018
Topicality. For treatment of cardiovascular diseases vegetative origin pharmacological preparations with metabolic and cytoprotective effects are increasingly used, but their range is rather limited.
Hladukh, V. Ye.   +7 more
core   +1 more source

Dexmedetomidine as a Cardioprotector in Cardiac Surgery (Review)

open access: yesОбщая реаниматология, 2017
The literature review presents an analysis of publications on the use of a selective α2-adrenergic receptor agonist (α2-AR) dexmedetomidine as a cardioprotector in cardiosurgical interventions. It summarizes historical aspects of the introduction of α2-AR agonists in the intensive care practice.
I. A. Kozlov, T. V. Klypa, I. O. Antonov
openaire   +1 more source

Some aspects of contemporary heart failure pharmacotherapy [PDF]

open access: yes, 2012
Introduction: Heart failure is a clinical syndrome with complex etiology, being the cause of hospitalization for one in three people on average, and the main cause of hospitalization for people aged over 65 years.
Chiriac, Valentina
core   +1 more source

THE EFFECT OF DIFFERENT DOSES OF COORDINATION COMPOUNDS OF GERMANIUM WITH NICOTINIC ACID ON LIPID PEROXIDATION AND COMPARATIVE INFLUENCE OF COORDINATION COMPOUNDS OF GERMANIUM WITH DIFFERENT BIOLIGANDS ON FATTY ACID SPECTRUM OF LIPIDS OF CARDIOMYOCYTES IN

open access: yesUkrainian Scientific Medical Youth Journal, 2016
According to the State Statistics Service, circulatory system diseases and malignant neoplasms take the first and second places among the causes of mortality in Ukraine. It is generally known that the basic chemotherapy principle is inhibition of mitotic
V.P. Narokha
doaj  

The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells

open access: yes, 2003
The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.
Abou el Hassan, M.A.   +5 more
core   +1 more source

METABOLIC CARDIOPROTECTOR THERAPY IN PEDIATRIC SPORTS MEDICINE

open access: yesРоссийский кардиологический журнал, 2011
Our previous studies have demonstrated the importance of early diagnostics and treatment of pathological cardiac transformations in young athletes. The present pilot clinical study is focused on cardioprotective effects of 2-ethyl-6-methyl-3-oxy-pyridine succinate (“Mexicor”, EcoPharmInvest) in young athletes with stress cardiomyopathy.
L. A. Balykova   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy